UK-based active pharmaceutical ingredient (API) manufacturer Onyx Scientific has secured a contract with drug-development company Nuformix to become one of its exclusive supply partners.
The solid-state team at Onyx is now working closely with virtual company Nuformix, which designs research programmes focused on the optimisation of drug solid form.
The team at Nuformix initially had a requirement to obtain robust data in order for it to understand and progress its development programmes.
After opting to use the services of Onyx, it sent representative samples to the Northern England-based organisation to test on its behalf and report back to assist development work.
After using its complementary equipment and integrated approach on the project, Nuformix officially appointed the contract chemistry specialist as its exclusive provider of characterisation support.
